fantomphan, you have no idea how the market thought of Singapore being added. This stock is heavily shorted. However, my point was the negativity of the board, yours included. You state that you are not short but you certainly post like you are, never a positive post. Also, I and I believe most shareholders do not want to sell the company, that just seems ridiculous as we near profitability and US FDA approval is on the horizon. Also, I don't agree with your characterization of the management team as clowns, they do seem competent, this is just a biotech in it's early stages.